• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET XL 360 SOFT 2MM X 6CM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET XL 360 SOFT 2MM X 6CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Model Number M0036122060
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/30/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H3 other text : the device is not available to the manufacturer.
 
Event or Problem Description
It was reported that during the procedure, the subject coil which was inserted as the tenth coil out of thirteen, was difficult to engage in the aneurysm and the physician had to reposition it several times.When the physician attempted to retrieve the subject coil, it was confirmed that the subject coil prematurely detached within the microcatheter and could not be removed.The subject coil was pushed into the aneurysm with the next coil and the procedure was completed successfully using the same microcatheter.No clinical consequences were reported to the patient due to this event.
 
Event or Problem Description
It was reported that during the procedure, the subject coil which was inserted as the tenth coil out of thirteen, was difficult to engage in the aneurysm and the physician had to reposition it several times.When the physician attempted to retrieve the subject coil, it was confirmed that the subject coil prematurely detached within the microcatheter and could not be removed.The subject coil was pushed into the aneurysm with the next coil and the procedure was completed successfully using the same microcatheter.No clinical consequences were reported to the patient due to this event.
 
Additional Manufacturer Narrative
Due to the automated manufacturing execution system (mes) there are controls in the manufacturing process to ensure the product met specifications upon release.The subject device is not available; therefore, functional testing as well as visual testing cannot be performed.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The reported complaint could not be confirmed, and it could not be definitively determined if the device failed to meet specifications because the product was not returned.Additional information provided by the customer indicated that the device was confirmed to be in good condition during preparation/prior to use on the patient and was prepared for use as per the dfu (except continuous flush was not set up and maintained throughout the clinical procedure), the tortuosity of the patient's anatomy was normal, the tapered distal end of the introducer sheath was firmly seated in the hub of the microcatheter, the whole coil was fully detached from the delivery wire, no attempt was made to detach the subject coil using a power supply, the prematurely detached coil was pushed into the aneurysm with the next coil, and the procedure was completed successfully using the same microcatheter.In the case of this complaint, it is probable that lack of continuous flush contributed to the reported event.Per the dfu: "in order to achieve optimal performance of the detachable coil system and to reduce the risk of thromboembolic complications, it is critical that a continuous infusion of appropriate flush solution be maintained between a) the femoral sheath and guiding catheter, b) the 2-tip microcatheter and guiding catheters, and c) the 2-tip microcatheter and stryker neurovascular guidewire and delivery wire.Continuous flush also reduces the potential for thrombus formation on, and crystallization of infusate around, the detachment zone of the detachable coil".An assignable cause of use error will be assigned to this complaint of 'main coil prematurely detached/separated during use' and 'device difficulty engaging target vessel' since there was a deviation from the supplied dfu that resulted in a different medical product response than intended by the manufacturer or expected by the user.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET XL 360 SOFT 2MM X 6CM
Common Device Name
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI  NA
Manufacturer (Section G)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
EI   NA
Manufacturer Contact
tara lopez
47900 bayside parkway
fremont, CA 94538
5104132500
MDR Report Key17373477
Report Number3008881809-2023-00370
Device Sequence Number15218992
Product Code HCG
UDI-Device Identifier07613327128260
UDI-Public07613327128260
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K153658
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/05/2025
Device Model NumberM0036122060
Device Catalogue NumberM0036122060
Device Lot Number24054790
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 07/03/2023
Supplement Date Received by Manufacturer08/21/2023
Initial Report FDA Received Date07/21/2023
Supplement Report FDA Received Date08/21/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured12/07/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
COILS (UNKNOWN).; MICROCATHETER (UNKNOWN).
Patient SexUnknown
-
-